Showing results (181-190 of 1,479) with videos related to
Sort By:
Pageof 148
Human Psychopharmacology|April 14, 2004
Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challengeNicola S GrayHuman Psychopharmacology|March 3, 2005
The effects of caffeine and expectancy on attention and memoryAdam Oei, Laurence R HartleyHuman Psychopharmacology|February 9, 2005
A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysisRobin D J Harry, Konstantine K ZakzanisHuman Psychopharmacology|July 2, 2005
One-year treatment of Alzheimer's disease with acetylcholinesterase inhibitors: improvement on ADAS-cog and TMT A, no change or worsening on other testsAlina Borkowska, Marzena Ziolkowska-Kochan, Janusz K RybakowskiHuman Psychopharmacology|March 3, 2004
Effects of a combined extract of Ginkgo biloba and Bacopa monniera on cognitive function in healthy humansPradeep J Nathan, Sally Tanner, Jenny Lloyd, et al.Human Psychopharmacology|March 3, 2004
Dosage finding and outcome in the treatment of schizophrenic inpatients with amisulpride. Results of a drug utilization observation studyMichael Linden, Tabea Scheel, Franz Xaver EichHuman Psychopharmacology|March 3, 2004
A pilot trial of quetiapine for the treatment of patients with deliriumChi-Un Pae, Soo-Jung Lee, Chang-Uk Lee, et al.Human Psychopharmacology|March 3, 2004
A randomized clinical trial comparing doses and efficacy of lormetazepam tablets or oral solution for insomnia in a general practice settingC Ancolio, S Tardieu, C Soubrouillard, et al.Human Psychopharmacology|October 9, 2003
Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular usersSuzanne L Verheyden, John A Henry, H Valerie CurranHuman Psychopharmacology|February 1, 2005
Is cannabis an anti-antipsychotic? The experience in psychiatric intensive careMaria Isaac, Michael Isaac, Frank HollowayPageof 148